Mell, L. K., Sacco, A. G., Zou, J., Wise-Draper, T. M., Sharabi, A., Julian, R. A., Zhang, J., Robbins, J., Caudell, J. J., Lockney, N. A., Gold, K. A., Bauman, J. E., Pittman, E., Yun, K. M., Sanghvi, P. R., Thorstad, W., Califano, J. A., Cohen, E. E., Messer, K., Adkins, D. (2026). Phase II randomized trial of radiotherapy with pembrolizumab vs. cisplatin for unfavorable-risk p16+ head and neck squamous cell carcinoma (KEYCHAIN).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.6016